Latest News in the pharma Industry
Research & Development
Shire’s SHP626 (volixibat) receives FDA fast track designation
29 Jul 2016
Designation is for an investigational treatment of adults who have nonalcoholic steatohepatitis (NASH) with liver fibrosis.
Read more
New studies suggest relationship between tau pathology and progression of Alzheimer's disease
28 Jul 2016
Analysis shows a correlation between tau tangles and cognitive decline in patients living with Alzheimer's disease.
Read more
Axol Bioscience and Metrion Biosciences announce research collaboration
26 Jul 2016
The human cell culture specialists join experts in ion channel research to study human iPSC-derived cardiomyocytes for drug discovery applications.
Read more
BMS announces new research collaboration with Janssen in immuno-oncology
26 Jul 2016
The research will evaluate Opdivo and live attenuated double–deleted Listerial monocytogenes cancer immunotherapy
Read more
Celgene decides against pursuing new indication for its Revlimid
26 Jul 2016
Data from a Phase III study indicate overall survival showed no benefit of Revlimid.
Read more
Alzheon presents positive results of ALZ-801 clinical studies
25 Jul 2016
Pharmacokinetic and safety data from Phase Ib studies with ALZ-801, an optimized prodrug of tramiprosate, presented at the Alzheimer's Association International Conference.
Read more
Allergan receives Positive Opinion For Truberzi for treatment of IBS-D in adults
25 Jul 2016
Significant step towards bringing the only licensed prescription medication for IBS-D to patients in 28 countries of the EU.
Read more
AbbVie and BMS announce oncology clinical collaboration to evaluate the combination of Rova-T plus Opdivo and Opdivo + Yervoy regimen
25 Jul 2016
Collaboration will explore the safety and potential enhanced efficacy of combining checkpoint inhibitors with a cancer stem cell-targeting antibody drug conjugate in SCLC.
Read more
N-of-One Secures $7 Million in Series B financing
24 Jul 2016
The financing will be used to expand the company's leading precision medicine decision support solutions in oncology.
Read more
MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities
17 Jul 2016
The charity will now also be able to pursue exciting novel research and development collaborations with new partners.
Read more
Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer
17 Jul 2016
Study to evaluate potential of novel combination therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative (HR+, HER2-) metastatic breast cancer (mBC).
Read more
Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class
14 Jul 2016
The collaboration will evaluate the use of Avacta’s Affimer technology in combination with Glythera’s PermaLink conjugation chemistry.
Read more